Zhenwu Li
11Patents
6h-index
26Co-inventors
58Inventor score
Filing activity: Feb 5, 2015 → Mar 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9944647B2 | Heterocyclic compounds as LSD1 inhibitors | Chemistry; Metallurgy | 29 | Active |
| US11407749B2 | Heterocyclic compounds as immunomodulators | Chemistry; Metallurgy | 19 | Active |
| US11608337B2 | Heterocyclic compounds as immunomodulators | Chemistry; Metallurgy | 12 | Active |
| US11596692B1 | PD-L1/STING conjugates and methods of use | Chemistry; Metallurgy | 8 | Active |
| US10800779B2 | Heterocyclic compounds as LSD1 inhibitors | Chemistry; Metallurgy | 6 | Active |
| US11472791B2 | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors | Physics | 6 | Active |
| US10947227B2 | Tricyclic heterocyclic compounds as sting activators | Chemistry; Metallurgy | 4 | Active |
| US11851426B2 | Bicyclic amines as CDK2 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11713317B2 | Tricyclic heterocyclic compounds as sting activators | Chemistry; Metallurgy | 2 | Active |
| US11401272B2 | Heterocyclic compounds as LSD1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9676788B2 | Aza-epoxy-guaiane derivatives and treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.